Bifunctional Bismuth‐Based Layered Double Hydroxide Sonosensitizer for Magnetic Resonance Imaging‐Guided Sonodynamic Cancer Therapy

Author:

Cao Min1,Yang Shuqing2,Li Jie3,Yang Yu2,Zhan Linsen1,Wang Tao2,Hu Tingting2,Liang Ruizheng24ORCID,Li Zhangping1

Affiliation:

1. The Quzhou Affiliated Hospital of Wenzhou Medical University Quzhou People's Hospital Quzhou Zhejiang 324000 P. R. China

2. State Key Laboratory of Chemical Resource Engineering Beijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P. R. China

3. College of Pharmacy Wenzhou Medical University Wenzhou 325000 P. R. China

4. Quzhou Institute for Innovation in Resource Chemical Engineering Quzhou 324000 P. R. China

Abstract

AbstractNovel inorganic sonosensitizers with excellent reactive oxygen species (ROS) generation activity and multifunctionality are appealing in sonodynamic therapy (SDT). Herein, amorphous bismuth (Bi)‐doped CoFe‐layered double hydroxide (a‐CoBiFe‐LDH) nanosheets are proposed via crystalline‐to‐amorphous phase transformation strategy as a new type of bifunctional sonosensitizer, which allows ultrasound (US) to trigger ROS generation for magnetic resonance imaging (MRI)‐guided SDT. Importantly, a‐CoBiFe‐LDH nanosheets exhibit much higher ROS generation activity (≈6.9 times) than that of traditional TiO2 sonosensitizer under US irradiation, which can be attributed to the acid etching‐induced narrow band gap, high electron (e)/hole (h+) separation efficiency and inhibited e/h+ recombination. In addition, the paramagnetic properties of Fe ion endow a‐CoBiFe‐LDH with excellent MRI contrast ability, making it a promising contrast agent for T2‐weighted MRI. After modification with polyethylene glycol, a‐CoBiFe‐LDH nanosheets can function as a high‐efficiency sonosensitizer to activate p53, MAPK, oxidative phosphorylation, and apoptosis‐related signaling pathways, ultimately inducing cell apoptosis in vitro and tumor ablation in vivo under US irradiation, which shows great potential for clinical cancer treatment.

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology

Excellent Young Scientists Fund

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3